These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25611337)

  • 1. Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways.
    Karagoz K; Sinha R; Arga KY
    OMICS; 2015 Feb; 19(2):115-30. PubMed ID: 25611337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
    Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
    Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation.
    Velloso FJ; Campos AR; Sogayar MC; Correa RG
    BMC Genomics; 2019 Feb; 20(1):152. PubMed ID: 30791886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
    Peng C; Ma W; Xia W; Zheng W
    Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
    Quintero M; Adamoski D; Reis LMD; Ascenção CFR; Oliveira KRS; Gonçalves KA; Dias MM; Carazzolle MF; Dias SMG
    BMC Cancer; 2017 Nov; 17(1):727. PubMed ID: 29115931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel inhibitor of triple-negative breast cancer cell growth by screening of a small-molecule library.
    Fujita T; Mizukami T; Okawara T; Inoue K; Fujimori M
    Breast Cancer; 2014 Nov; 21(6):738-47. PubMed ID: 23456737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications.
    Millis SZ; Gatalica Z; Winkler J; Vranic S; Kimbrough J; Reddy S; O'Shaughnessy JA
    Clin Breast Cancer; 2015 Dec; 15(6):473-481.e3. PubMed ID: 26051240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.
    Zhao C; Qiao Y; Jonsson P; Wang J; Xu L; Rouhi P; Sinha I; Cao Y; Williams C; Dahlman-Wright K
    Cancer Res; 2014 Jul; 74(14):3983-94. PubMed ID: 24830720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs-mediated cell fate in triple negative breast cancers.
    Sui X; Wang X; Han W; Li D; Xu Y; Lou F; Zhou J; Gu X; Zhu J; Zhang C; Pan H
    Cancer Lett; 2015 May; 361(1):8-12. PubMed ID: 25748387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative network-based approach identifies central genetic and transcriptomic elements in triple-negative breast cancer.
    Sriroopreddy R; Sudandiradoss C
    Funct Integr Genomics; 2018 Mar; 18(2):113-124. PubMed ID: 29260344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of sample-specific regulations using integrative network level analysis.
    Liu C; Louhimo R; Laakso M; Lehtonen R; Hautaniemi S
    BMC Cancer; 2015 Apr; 15():319. PubMed ID: 25928379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New targets for triple-negative breast cancer.
    Herold CI; Anders CK
    Oncology (Williston Park); 2013 Sep; 27(9):846-54. PubMed ID: 24282978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting a cell state common to triple-negative breast cancers.
    Muellner MK; Mair B; Ibrahim Y; Kerzendorfer C; Lechtermann H; Trefzer C; Klepsch F; Müller AC; Leitner E; Macho-Maschler S; Superti-Furga G; Bennett KL; Baselga J; Rix U; Kubicek S; Colinge J; Serra V; Nijman SM
    Mol Syst Biol; 2015 Feb; 11(1):789. PubMed ID: 25699542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
    Naorem LD; Muthaiyan M; Venkatesan A
    J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of
    Wang F; Cao X; Yin L; Wang Q; He Z
    DNA Cell Biol; 2020 Oct; 39(10):1813-1824. PubMed ID: 32816580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances of transcriptomics and proteomics in triple-negative breast cancer prognosis assessment.
    Li Y; Kong X; Wang Z; Xuan L
    J Cell Mol Med; 2022 Mar; 26(5):1351-1362. PubMed ID: 35150062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer.
    Yotsumoto F; Tokunaga E; Oki E; Maehara Y; Yamada H; Nakajima K; Nam SO; Miyata K; Koyanagi M; Doi K; Shirasawa S; Kuroki M; Miyamoto S
    Mol Cancer Res; 2013 May; 11(5):506-17. PubMed ID: 23443317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of dysregulated microRNAs in triple-negative breast cancer (review).
    Yang F; Zhang W; Shen Y; Guan X
    Int J Oncol; 2015 Mar; 46(3):927-32. PubMed ID: 25571912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer.
    Kim JY; Lee H; Woo J; Yue W; Kim K; Choi S; Jang JJ; Kim Y; Park IA; Han D; Ryu HS
    Sci Rep; 2017 Jun; 7(1):3466. PubMed ID: 28615672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.